Literature DB >> 20851644

Hepatitis B genotype C correlated with poor surgical outcomes for hepatocellular carcinoma.

Tsung-Jung Liang1, King-Tong Mok, Shiuh-Inn Liu, Shiu-Feng Huang, Nan-Hua Chou, Cheng-Chung Tsai, I-Shu Chen, Ming-Hsin Yeh, Yu-Chia Chen, Being-Whey Wang.   

Abstract

BACKGROUND: Genotype B and C are the predominant hepatitis B virus (HBV) strains in Taiwan. We aimed to investigate the role of genotype in HBV-related hepatocellular carcinoma (HCC) after resection. STUDY
DESIGN: From October 2005 to November 2008, 64 patients who underwent liver resection for HBV-related HCC were enrolled. HBV genotypes were determined by molecular method. Patient characteristics, biochemical, tumor, and viral factors were evaluated for their prognostic significance.
RESULTS: During a mean follow-up of 26.6 ± 13.2 months, patients infected with genotype C had higher HBV viral load (p = 0.007) and worse disease-free survival rate (p = 0.028) than patients with genotype B. By univariate analysis, genotype C, alanine transaminase >50 U/L, tumor size ≥5 cm, and microvascular invasion were associated with tumor recurrence. Further multivariate analysis demonstrated genotype C remained a significant risk factor (p = 0.034).
CONCLUSIONS: Genotype C is a strong risk factor for HCC recurrence after resection. More intensive monitoring for recurrence should be considered in patients with genotype C.
Copyright © 2010 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851644     DOI: 10.1016/j.jamcollsurg.2010.06.020

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

Review 1.  Is there any value to hepatitis B virus genotype analysis?

Authors:  Sudeep Tanwar; Geoffrey Dusheiko
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 2.  Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia.

Authors:  Qiuju Tian; Jidong Jia
Journal:  Hepatol Int       Date:  2016-06-14       Impact factor: 6.047

Review 3.  Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.

Authors:  Yi-Fang Han; Jun Zhao; Li-Ye Ma; Jian-Hua Yin; Wen-Jun Chang; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

4.  The characteristic changes in hepatitis B virus x region for hepatocellular carcinoma: a comprehensive analysis based on global data.

Authors:  Wenwen Li; Kaku Goto; Yasuo Matsubara; Sayaka Ito; Ryosuke Muroyama; Qiang Li; Naoya Kato
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

5.  HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma.

Authors:  Zijun Ge; Ting Tian; Lijuan Meng; Ci Song; Chengxiao Yu; Xin Xu; Jibin Liu; Juncheng Dai; Zhibin Hu
Journal:  Cancer Med       Date:  2019-04-29       Impact factor: 4.452

6.  The contribution of serum hepatitis B virus load in the carcinogenesis and prognosis of hepatocellular carcinoma: evidence from two meta-analyses.

Authors:  Xueqin Chen; Fan Wu; Yanmei Liu; Jiao Lou; Beibei Zhu; Li Zou; Wei Chen; Jing Gong; Ying Wang; Rong Zhong
Journal:  Oncotarget       Date:  2016-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.